Joslin Diabetes Center

And just this past week, they broke ground on a new facility, the Levine-Beckenstein Cancer Hospital.

It's a 450,000 square foot facility, located where the Joslin Diabetes Center was, right there on Brookline Avenue.

This new hospital will care for many with up to 300 inpatient beds.

And the fact that it's so close to other researchers and clinicians, well, this will only help to coordinate outpatient care.

But even in modern medicine in the United States in that early part of the last century, 100 years ago, before a lot of the medications had been invented, the treatment for diabetes was a low carbohydrate diet along with exercise.

Doctors knew and commonly prescribed basically sort of ketogenic diets Even 100 years ago, Joslin, who founded the Joslin Diabetes Center, this was a major, major treatment.

They understood that ketogenic diets, for example, were important for epilepsy.

And doctors, even before gluten was a known thing, would tell people to go off wheat when they had significant gastrointestinal distress that turned out to be celiac disease.

So that's what I, I wanted to figure out the molecular mechanism.

So and then actually I moved to Joslin Diabetes Center in Boston, where actually people study how insulin regulate glucose metabolism.

So what I saw was that insulin has fine, uh, signaling system to mediate chemical message of ma- you know, insulin in the cells to transduce a signal to update glucose, for example, and store them as a glycogen.

So-

My guest today is a man who has spent his entire career on the front lines of pediatric diabetes care, not just in one country, but internationally.

He trained in Berlin, worked at Joslin Diabetes Center, ran Germany's largest pediatric diabetes center for nearly two decades, and has served as president of both the International Society for Pediatric and Adolescent Diabetes and the German Diabetes Association.

Today, he serves as the chief medical officer of Breakthrough T1D, the organization hosting this very event, where his entire mission is to close the gap between the breakthroughs happening in research labs and the real people who need them.

Today, we are talking about what Breakthrough T1D is doing to end Type 1 diabetes, the research, the investments, and the steps that stand between where we are today and a world where no one has to inject insulin.